サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629252

神経遺伝学的検査の世界市場：検査の種類別・技術別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Neurogenetic Testing Market, By Test Type, By Technology, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 355 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
神経遺伝学的検査の世界市場：検査の種類別・技術別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 355 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

神経遺伝学的検査市場規模は2024年に7億8,625万米ドルとなり、2025年から2032年にかけてCAGR 12.2%で拡大

神経遺伝学的検査の市場力学

神経疾患管理における個別化医療への需要の高まり

神経疾患管理における個別化医療への需要の高まりが、神経遺伝学的検査市場の主要な促進要因です。個別化医療は、個人の遺伝子プロファイルに基づいて治療を調整し、より正確で効果的な介入を可能にします。アルツハイマー病、パーキンソン病、ハンチントン病などの神経疾患は遺伝的要因の影響を受けるため、患者の遺伝子構成を理解することは、最も適した治療を特定するのに役立ちます。このアプローチは試行錯誤の方法を減らし、患者の転帰を改善します。医療提供者と患者の間で個別化医療の利点が認識されるようになったことで、遺伝子検査の普及が進んでいます。医療業界がより的を絞った個別化医療を目指すようになるにつれ、神経遺伝学的検査の需要は拡大し、神経疾患の精密治療が進むと予想されます。

神経遺伝学的検査市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2025-2032年) に約12.2%のCAGRで毎年成長すると推定されます。

検査の種類別に見ると、出生前遺伝子検査が2024年に最大市場シェアを示すと予測されました。

技術別では、次世代シーケンシング (NGS) が2024年の主要技術でした。

用途別では、アルツハイマー病が2024年の主要アプリケーションでした。

地域別では、北米が2024年の売上高でトップ

神経遺伝学的検査市場：セグメンテーション分析

神経遺伝学的検査の世界市場は、検査の種類、技術、用途、エンドユーザー、地域に基づいて区分されます。

市場は検査の種類に基づいて3つのカテゴリーに分けられます：出生前遺伝子検査、キャリアスクリーニング、診断検査、予測検査です。出生前遺伝子検査は、神経遺伝学的検査市場で最も顕著なセグメントです。このセグメントは、胎児における遺伝性疾患の早期発見に対する認識と需要の高まりにより、大きな牽引力となっています。出生前検査は、ダウン症候群、嚢胞性線維症、その他の神経疾患のような遺伝的疾患を特定するのに役立ち、出産を控えた両親に貴重な情報を提供します。非侵襲的出生前検査 (NIPT) の増加と技術の進歩により、これらの検査はより身近で正確なものとなっています。早期の疾病予防に注目が集まる中、出生前遺伝子検査は広く採用され、市場成長を牽引しています。この分野は、検査精度を向上させ、従来の検査法に伴うリスクを軽減する次世代シーケンシング (NGS) 技術の進歩が続いていることから、特にその優位性を維持すると予想されます。

同市場は技術によって2つのカテゴリーに分けられます：次世代シーケンシング (NGS)、ポリメラーゼ連鎖反応 (PCR)、マイクロアレイ、蛍光in situハイブリダイゼーション (FISH)、その他です。次世代シーケンシング (NGS) は、神経遺伝学的検査市場で最も顕著な技術です。NGSは、遺伝物質のハイスループット、正確かつ効率的な解析を可能にし、遺伝子変異に関連する神経疾患を特定するための強力なツールとなっています。短時間で膨大な遺伝子データの配列を決定するその能力は、特にアルツハイマー病、パーキンソン病、ハンチントン病のような複雑な神経疾患の診断において、遺伝子検査に革命をもたらしました。NGSは、個別化治療アプローチに不可欠な遺伝子変異や突然変異に関する詳細な洞察を提供します。NGSの採用が増加している背景には、その費用対効果、精度の高さ、精密医療への需要の高まりがあります。継続的な進歩により、NGSは優位性を維持し、神経遺伝学的診断の将来において中心的な役割を果たすと予想されます。

神経遺伝学的検査市場：地域別分析

北米は神経遺伝学的検査市場の主要企業であり、その主な理由は先進医療インフラ、遺伝子検査に対する高い認識、主要企業の強い存在感です。米国は、遺伝子検査の普及と神経疾患の研究が盛んであり、大きな貢献をしています。欧州は、個別化医療への注目の高まりと遺伝子研究に対する政府助成金の増加により、その後に続いています。アジア太平洋地域も著しい成長を遂げており、特に中国やインドのような国々では、医療制度の改善や遺伝子検査に対する意識の高まりが需要を促進しています。さらに、ラテンアメリカと中東は、医療投資の増加と医療ニーズの高まりにより、潜在的な市場として徐々に台頭してきています。

米国では、高度な医療インフラ、遺伝子検査の普及、個別化医療への強い関心が神経遺伝学的検査市場を牽引しています。主要企業や研究機関の存在と、遺伝子研究を支援する政府の取り組みが、この市場の急成長と技術革新に寄与しています。

神経遺伝学的検査市場：競合情勢

神経遺伝学的検査市場の競合情勢は、確立された診断大手と遺伝子検査専門企業が混在して形成されています。イルミナ、サーモフィッシャーサイエンティフィック、クエスト・ダイアグノスティックスのような企業は、広範な遺伝子検査ポートフォリオと強力な販売網で優位を占めています。Fulgent GeneticsやGeneDxのような中小企業は、次世代シーケンシングのような革新的技術を活用して神経疾患の精密診断を提供する、専門的な検査サービスに注力しています。また、遺伝子検査企業と医療プロバイダーとの連携が進み、検査へのアクセスが向上しています。個別化医療に対する需要の高まりに伴い、各社は遺伝子検査能力の拡充に投資し、検査結果を改善するために人工知能を統合しています。競争圧力は継続的な技術革新を促し、市場を非常にダイナミックなものにしており、新規参入企業は急速に進化する神経遺伝学的検査分野で未開拓の機会を探っています。

目次

第1章 神経遺伝学的検査市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 神経遺伝学的検査の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 神経遺伝学的検査市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 神経遺伝学的検査市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 神経遺伝学的検査の市場情勢

  • 神経遺伝学的検査の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 神経遺伝学的検査市場：検査の種類別

  • 概要
    • セグメント別シェア分析：検査の種類別
    • 出生前遺伝子検査
    • キャリアスクリーニング
    • 診断検査
    • 予測検査

第8章 神経遺伝学的検査市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • 次世代シーケンシング (NGS)
    • ポリメラーゼ連鎖反応 (PCR)
    • マイクロアレイ
    • 蛍光in situハイブリダイゼーション (FISH)
    • その他

第9章 神経遺伝学的検査市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • アルツハイマー病
    • パーキンソン病
    • ハンチントン病
    • てんかん
    • 多発性硬化症
    • その他

第10章 神経遺伝学的検査市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院
    • 診断検査室
    • 研究機関
    • 遺伝カウンセリングセンター

第11章 神経遺伝学的検査市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ (LATAM)
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ (MEA)
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：神経遺伝学的検査業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • 23andMe
    • Invitae Corporation
    • Fulgent Genetics
    • Illumina
    • LabCorp
    • Quest Diagnostics
    • GeneDx
    • BioReference Laboratories
    • Arup Laboratories
    • Asuragen
    • Thermo Fisher Scientific
    • NextBio
    • NeoGenomics
    • Eurofins Scientific
    • Myriad Genetics
    • Centogene
    • Genetic Health Inc.

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4572

REPORT HIGHLIGHT

Neurogenetic Testing Market size was valued at US$ 786.25 Million in 2024, expanding at a CAGR of 12.2% from 2025 to 2032.

The neurogenetic testing market focuses on diagnostic tests that identify genetic variations linked to neurological disorders. These tests are crucial for diagnosing conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and various genetic neuropathies. Neurogenetic testing can help in understanding disease progression, selecting appropriate treatments, and predicting risk for family members. The market is driven by advances in genetic research, increasing awareness of personalized medicine, and growing demand for early disease detection. Technological advancements like next-generation sequencing (NGS) are enhancing the accuracy and efficiency of these tests. With a rise in genetic counseling services and healthcare's shift toward precision medicine, the demand for neurogenetic tests is expected to continue growing. The market also faces challenges related to ethical concerns, insurance coverage, and the need for regulation in testing practices.

Neurogenetic Testing Market- Market Dynamics

Increasing demand for personalized medicine in neurological disease management.

The growing demand for personalized medicine in neurological disease management is a key driver for the neurogenetic testing market. Personalized medicine tailors treatments based on individual genetic profiles, allowing for more precise and effective interventions. As neurological conditions like Alzheimer's, Parkinson's, and Huntington's disease are influenced by genetic factors, understanding a patient's genetic makeup helps identify the most suitable treatments. This approach reduces trial-and-error methods, improving patient outcomes. The increasing recognition of the benefits of personalized medicine among healthcare providers and patients has led to more widespread adoption of genetic testing. As the healthcare industry moves toward more targeted and individualized care, the demand for neurogenetic testing is expected to grow, advancing precision therapies for neurological disorders.

Neurogenetic Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.2% over the forecast period (2025-2032)

Based on Test Type segmentation, Prenatal Genetic Testing was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Next-Generation Sequencing (NGS) was the leading Technology in 2024

Based on Application segmentation, Alzheimer's Disease was the leading Application in 2024

Based on region, North America was the leading revenue generator in 2024

Neurogenetic Testing Market- Segmentation Analysis:

The Global Neurogenetic Testing Market is segmented based on Test Type, Technology, Application, End-User, and Region.

The market is divided into three categories based on Test Type: Prenatal Genetic Testing, Carrier Screening, Diagnostic Testing, and Predictive Testing. Prenatal Genetic Testing is the most prominent segment in the neurogenetic testing market. This segment has gained significant traction due to increasing awareness and demand for early detection of genetic disorders in unborn children. Prenatal testing helps identify genetic conditions like Down syndrome, cystic fibrosis, and other neurological disorders, providing valuable information for expecting parents. The rise in non-invasive prenatal testing (NIPT) and advancements in technology have made these tests more accessible and accurate. With a growing focus on early disease prevention, prenatal genetic testing is being adopted widely, driving market growth. This segment is expected to maintain its prominence, particularly with the ongoing advancements in next-generation sequencing (NGS) technologies, which improve testing accuracy and reduce risks associated with traditional testing methods.

The market is divided into two categories based on Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Fluorescence in situ Hybridization (FISH), Others. Next-Generation Sequencing (NGS) is the most prominent technology in the neurogenetic testing market. NGS allows for high-throughput, accurate, and efficient analysis of genetic material, making it a powerful tool for identifying neurological disorders linked to genetic mutations. Its ability to sequence vast amounts of genetic data in a short time has revolutionized genetic testing, particularly in diagnosing complex neurological diseases like Alzheimer's, Parkinson's, and Huntington's disease. NGS provides detailed insights into genetic variations and mutations that are critical for personalized treatment approaches. The growing adoption of NGS is driven by its cost-effectiveness, high accuracy, and the increasing demand for precision medicine. With continuous advancements, NGS is expected to maintain its dominance and play a central role in the future of neurogenetic diagnostics.

Neurogenetic Testing Market- Geographical Insights

North America is the leading region in the neurogenetic testing market, primarily due to advanced healthcare infrastructure, high awareness about genetic testing, and a strong presence of key companies. The U.S. is a major contributor, with widespread adoption of genetic testing and robust research in neurological diseases. Europe follows closely, driven by the growing focus on personalized medicine and increasing government funding for genetic research. The Asia-Pacific region is also witnessing significant growth, particularly in countries like China and India, where improving healthcare systems and rising awareness about genetic testing are fueling demand. Additionally, Latin America and the Middle East are gradually emerging as potential markets due to increasing healthcare investments and rising healthcare needs.

In the United States, the neurogenetic testing market is driven by advanced healthcare infrastructure, widespread adoption of genetic testing, and a strong focus on personalized medicine. The presence of leading companies and research institutions, along with government initiatives supporting genetic research, contributes to the rapid growth and innovation in this market.

Neurogenetic Testing Market- Competitive Landscape:

The competitive landscape of the neurogenetic testing market is shaped by a mix of established diagnostic giants and specialized genetic testing firms. Companies like Illumina, Thermo Fisher Scientific, and Quest Diagnostics dominate with extensive genetic testing portfolios and strong distribution networks. Smaller players such as Fulgent Genetics and GeneDx focus on specialized testing services, leveraging innovative technologies like next-generation sequencing to offer precise diagnostics for neurological disorders. The market is also witnessing increasing collaboration between genetic testing firms and healthcare providers, enhancing the accessibility of testing. With the rising demand for personalized medicine, players are investing in expanding their genetic testing capabilities and integrating artificial intelligence for improved test results. The competitive pressure encourages continuous innovation, making the market highly dynamic, with new entrants exploring untapped opportunities in the rapidly evolving field of neurogenetic testing.

Recent Developments:

In February 2024, Sysmex Corporation and Hitachi High-Tech Corporation announced a collaboration to develop genetic testing systems utilizing capillary electrophoresis sequencers (CE sequencers). This partnership aims to expand its presence in untapped economies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROGENETIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 23andMe
  • Invitae Corporation
  • Fulgent Genetics
  • Illumina
  • LabCorp
  • Quest Diagnostics
  • GeneDx
  • BioReference Laboratories
  • Arup Laboratories
  • Asuragen
  • Thermo Fisher Scientific
  • NextBio
  • NeoGenomics
  • Eurofins Scientific
  • Myriad Genetics
  • Centogene
  • Genetic Health Inc.

GLOBAL NEUROGENETIC TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prenatal Genetic Testing
  • Carrier Screening
  • Diagnostic Testing
  • Predictive Testing

GLOBAL NEUROGENETIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Fluorescence in situ Hybridization (FISH)
  • Others

GLOBAL NEUROGENETIC TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Alzheimer's Disease
  • Parkinson's Disease
  • Huntington's Disease
  • Epilepsy
  • Multiple Sclerosis
  • Others

GLOBAL NEUROGENETIC TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Genetic Counseling Center

GLOBAL NEUROGENETIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neurogenetic Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neurogenetic Testing Market Snippet by Test Type
    • 2.1.2. Neurogenetic Testing Market Snippet by Technology
    • 2.1.3. Neurogenetic Testing Market Snippet by Application
    • 2.1.4. Neurogenetic Testing Market Snippet by End-User
    • 2.1.5. Neurogenetic Testing Market Snippet by Country
    • 2.1.6. Neurogenetic Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Neurogenetic Testing Key Market Trends

  • 3.1. Neurogenetic Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neurogenetic Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neurogenetic Testing Market Opportunities
  • 3.4. Neurogenetic Testing Market Future Trends

4. Neurogenetic Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neurogenetic Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Neurogenetic Testing Market Landscape

  • 6.1. Neurogenetic Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neurogenetic Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Prenatal Genetic Testing
    • 7.1.3. Carrier Screening
    • 7.1.4. Diagnostic Testing
    • 7.1.5. Predictive Testing

8. Neurogenetic Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Next-Generation Sequencing (NGS)
    • 8.1.3. Polymerase Chain Reaction (PCR)
    • 8.1.4. Microarray
    • 8.1.5. Fluorescence in situ Hybridization (FISH)
    • 8.1.6. Others

9. Neurogenetic Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Alzheimer's Disease
    • 9.1.3. Parkinson's Disease
    • 9.1.4. Huntington's Disease
    • 9.1.5. Epilepsy
    • 9.1.6. Multiple Sclerosis
    • 9.1.7. Others

10. Neurogenetic Testing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutes
    • 10.1.5. Genetic Counseling Center

11. Neurogenetic Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Neurogenetic Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Neurogenetic Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Neurogenetic Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Neurogenetic Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Neurogenetic Testing Key Manufacturers in the Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Neurogenetic Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. 23andMe
    • 12.2.2. Invitae Corporation
    • 12.2.3. Fulgent Genetics
    • 12.2.4. Illumina
    • 12.2.5. LabCorp
    • 12.2.6. Quest Diagnostics
    • 12.2.7. GeneDx
    • 12.2.8. BioReference Laboratories
    • 12.2.9. Arup Laboratories
    • 12.2.10. Asuragen
    • 12.2.11. Thermo Fisher Scientific
    • 12.2.12. NextBio
    • 12.2.13. NeoGenomics
    • 12.2.14. Eurofins Scientific
    • 12.2.15. Myriad Genetics
    • 12.2.16. Centogene
    • 12.2.17. Genetic Health Inc.

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us